{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:56:54Z","timestamp":1769173014343,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874310"],"award-info":[{"award-number":["81874310"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s11011-021-00783-8","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T12:02:48Z","timestamp":1631793768000},"page":"2243-2253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Involvement of the nociceptin opioid peptide receptor in morphine-induced antinociception, tolerance and physical dependence in female mice"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9399-8927","authenticated-orcid":false,"given":"Xiao-Qing","family":"Hao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1664-7138","authenticated-orcid":false,"given":"Zhi-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4530-1256","authenticated-orcid":false,"given":"Jian-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5750-5750","authenticated-orcid":false,"given":"Ning","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0866-5483","authenticated-orcid":false,"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"key":"783_CR1","doi-asserted-by":"publisher","unstructured":"Ahmed A, Khan F, Ali M, Haqnawaz F, Hussain A, Azam SI (2012) Effect of the menstrual cycle phase on post-operative pain perception and analgesic requirements. Acta Anaesthesiol Scand 56: 629\u201335. https:\/\/doi.org\/10.1111\/j.1399-6576.2012.02661.x","DOI":"10.1111\/j.1399-6576.2012.02661.x"},{"key":"783_CR2","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.bja.2018.06.024","volume":"121","author":"G Calo","year":"2018","unstructured":"Calo G, Lambert DG (2018) Nociceptin\/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic. Br J Anaesth 121:1105\u20131114. https:\/\/doi.org\/10.1016\/j.bja.2018.06.024","journal-title":"Br J Anaesth"},{"key":"783_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1124\/jpet.106.103960","volume":"318","author":"S Chung","year":"2006","unstructured":"Chung S, Pohl S, Zeng J, Civelli O, Reinscheid RK (2006) Endogenous orphanin FQ\/nociceptin is involved in the development of morphine tolerance. J Pharmacol Exp Ther 318:262\u2013267. https:\/\/doi.org\/10.1124\/jpet.106.103960","journal-title":"J Pharmacol Exp Ther"},{"key":"783_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/s0014-2999(00)00590-2","volume":"404","author":"R Ciccocioppo","year":"2000","unstructured":"Ciccocioppo R, Angeletti S, Sanna PP, WeissF MassiM (2000) Effect of nociceptin\/orphanin FQ on the rewarding properties of morphine. Eur J Pharmacol 404:153\u2013159. https:\/\/doi.org\/10.1016\/s0014-2999(00)00590-2","journal-title":"Eur J Pharmacol"},{"key":"783_CR5","first-page":"767","volume":"279","author":"TJ Cicero","year":"1996","unstructured":"Cicero TJ, Nock B, Meyer ER (1996) Gender-related differences in the antinociceptive properties of morphine. J Pharmacol Exp Ther 279:767\u2013773","journal-title":"J Pharmacol Exp Ther"},{"key":"783_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1124\/jpet.112.194308","volume":"343","author":"CM Cremeans","year":"2012","unstructured":"Cremeans CM, Gruley E, KyleDJ, Ko MC (2012) Roles of \u00b5-opioid receptors and nociceptin\/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates. J Pharmacol Exp Ther 343:72\u201381. https:\/\/doi.org\/10.1124\/jpet.112.194308","journal-title":"J Pharmacol Exp Ther"},{"key":"783_CR7","first-page":"812","volume":"298","author":"FM Dautzenberg","year":"2001","unstructured":"Dautzenberg FM, Wichmann J, Higelin J, Py-Lang G, Kratzeisen C, Malherbe P, KilpatrickGJJenck F (2001) Pharmacological characterization of the novel nonpeptide orphanin FQ\/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitroand lack of tolerance in vivo. J Pharmacol Exp Ther 298:812\u2013819","journal-title":"J Pharmacol Exp Ther"},{"key":"783_CR8","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1074\/jbc.M109.040634","volume":"285","author":"RM Evans","year":"2010","unstructured":"Evans RM, You H, Hameed S, Altier C, Mezghrani A, BourinetE, Zamponi GW (2010) Heterodimerization of ORL1 and opioid receptors and its consequences for N-type calcium channel regulation. J Biol Chem 285:1032\u20131040. https:\/\/doi.org\/10.1074\/jbc.M109.040634","journal-title":"J Biol Chem"},{"key":"783_CR9","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/nmo.12390","volume":"26","author":"J Fichna","year":"2014","unstructured":"Fichna J, Sobczak M, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Cenac N, Sa\u0142aga M, Timmermans JP, Vergnolle N, Ma\u0142ecka-Panas E, Krajewska WM, Storr M (2014) Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS. Neurogastroenterol Motil 26:1539\u20131550. https:\/\/doi.org\/10.1111\/nmo.12390","journal-title":"Neurogastroenterol Motil"},{"key":"783_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0006-8993(00)02669-x","volume":"880","author":"S Florin","year":"2000","unstructured":"Florin S, MeunierJ, Costentin J (2000) Autoradiographic localization of [3H]nociceptinbinding sites in the rat brain. Brain Res 880:11\u201316. https:\/\/doi.org\/10.1016\/s0006-8993(00)02669-x","journal-title":"Brain Res"},{"key":"783_CR11","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1152\/jn.1997.78.6.3351","volume":"78","author":"MM Heinricher","year":"1997","unstructured":"Heinricher MM, McGaraughty S, Grandy DK (1997) Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla. J Neurophysiol 78:3351\u20133358. https:\/\/doi.org\/10.1152\/jn.1997.78.6.3351","journal-title":"J Neurophysiol"},{"key":"783_CR12","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1073\/pnas.090514397","volume":"97","author":"F Jenck","year":"2000","unstructured":"Jenck F, Wichmann J, Dautzenberg FM, Moreau JL, Ouagazzal AM, Martin JR, Lundstrom K, Cesura AM, Poli SM, Roever S, Kolczewski S, AdamG, Kilpatrick G (2000) A synthetic agonist at the orphanin FQ\/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc Natl Acad Sci USA 97:4938\u20134943. https:\/\/doi.org\/10.1073\/pnas.090514397","journal-title":"Proc Natl Acad Sci USA"},{"key":"783_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0091-3057(89)90363-8","volume":"34","author":"KL Kepler","year":"1989","unstructured":"Kepler KL, Kest B, Kiefel JM, Cooper ML, Bodnar RJ (1989) Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in rats. Pharmacol Biochem Behav 34:119\u2013127. https:\/\/doi.org\/10.1016\/0091-3057(89)90363-8","journal-title":"Pharmacol Biochem Behav"},{"key":"783_CR14","first-page":"1370","volume":"289","author":"B Kest","year":"1999","unstructured":"Kest B, Wilson SG, Mogil JS (1999) Sex differences in supraspinal morphine analgesia are dependent on genotype. J Pharmacol Exp Ther 289:1370\u20131375","journal-title":"J Pharmacol Exp Ther"},{"key":"783_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/s0306-4522(01)00037-9","volume":"104","author":"B Kest","year":"2001","unstructured":"Kest B, Hopkins E, Palmese CA, Chen ZP, Mogil JS, Pintar JE (2001) Morphine tolerance and dependence in nociceptin\/orphanin FQ transgenic knock-out mice. Neuroscience 104:217\u2013222. https:\/\/doi.org\/10.1016\/s0306-4522(01)00037-9","journal-title":"Neuroscience"},{"key":"783_CR16","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1124\/jpet.106.111997","volume":"320","author":"TV Khroyan","year":"2007","unstructured":"Khroyan TV, Zaveri NT, Polgar WE, Orduna J, Olsen C, Jiang F, Toll L (2007) SR 16435 [1-(1-(bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a novel mixed nociceptin\/orphanin FQ\/mu-opioid receptor partial agonist: analgesic and rewarding properties in mice. J Pharmacol Exp Ther 320:934\u2013943. https:\/\/doi.org\/10.1124\/jpet.106.111997","journal-title":"J Pharmacol Exp Ther"},{"key":"783_CR17","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1124\/jpet.109.156711","volume":"331","author":"TV Khroyan","year":"2009","unstructured":"Khroyan TV, Polgar WE, Jiang F, ZaveriNT, Toll L (2009) Nociceptin\/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin\/orphanin FQ\/mu-opioid receptor agonists. J Pharmacol Exp Ther 331:946\u2013953. https:\/\/doi.org\/10.1124\/jpet.109.156711","journal-title":"J Pharmacol Exp Ther"},{"key":"783_CR18","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1124\/jpet.110.175620","volume":"336","author":"TV Khroyan","year":"2011","unstructured":"Khroyan TV, Polgar WE, Cami-Kobeci G, Husbands SM, ZaveriNT, Toll L (2011) The first universal opioid ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): characterization of the in vitro profile and in vivo behavioral effects in mouse models of acute pain and cocaine-induced reward. J Pharmacol Exp Ther 336:952\u2013961. https:\/\/doi.org\/10.1124\/jpet.110.175620","journal-title":"J Pharmacol Exp Ther"},{"key":"783_CR19","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1038\/npp.2009.33","volume":"34","author":"MC Ko","year":"2009","unstructured":"Ko MC, Woods JH, Fantegrossi WE, Galuska CM, WichmannJ, Prinssen EP (2009) Behavioral effects of a synthetic agonist selective for nociceptin\/orphanin FQ peptide receptors in monkeys. Neuropsychopharmacology 34:2088\u20132096. https:\/\/doi.org\/10.1038\/npp.2009.33","journal-title":"Neuropsychopharmacology"},{"key":"783_CR20","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/s0024-3205(99)00648-7","volume":"66","author":"J Kotlinska","year":"2000","unstructured":"Kotlinska J, Suder P, Legowska A, RolkaK, Silberring J (2000) Orphanin FQ\/nociceptin inhibits morphine withdrawal. Life Sci 66:1119\u20131123. https:\/\/doi.org\/10.1016\/s0024-3205(99)00648-7","journal-title":"Life Sci"},{"key":"783_CR21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/00001756-200303240-00015","volume":"14","author":"J Kotlinska","year":"2003","unstructured":"Kotlinska J, Wichmann J, Rafalski P, Talarek S, DylagT, Silberring J (2003) Non-peptidergicOP4 receptor agonist inhibits morphine antinociception but does not influence morphine dependence. Neuroreport 14:601\u2013604. https:\/\/doi.org\/10.1097\/00001756-200303240-00015","journal-title":"Neuroreport"},{"key":"783_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1124\/jpet.114.213694","volume":"349","author":"K Linz","year":"2014","unstructured":"Linz K, Christoph T, Tzschentke TM, Koch T, Schiene K, Gautrois M, Schroder W, K\u00f6gel BY, Beier H, Englberger W, Schunk S, DeVry J, JahnelU, Frosch S (2014) Cebranopadol: a novel potent analgesic nociceptin\/orphanin FQ peptide and opioid receptor agonist. J Pharmacol Exp Ther 349:535\u2013548. https:\/\/doi.org\/10.1124\/jpet.114.213694","journal-title":"J Pharmacol Exp Ther"},{"key":"783_CR23","doi-asserted-by":"publisher","first-page":"14007","DOI":"10.1523\/jneurosci.4123-08.2008","volume":"28","author":"DR Loyd","year":"2008","unstructured":"Loyd DR, Wang X, Murphy AZ (2008) Sex differences in micro-opioid receptor expression in the rat midbrain periaqueductal gray are essential for eliciting sex differences in morphine analgesia. J Neurosci 28: 14007\u201314017. https:\/\/doi.org\/10.1523\/jneurosci.4123-08.2008","journal-title":"J Neurosci"},{"key":"783_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/sj.bjp.0704279","volume":"134","author":"K Lutfy","year":"2001","unstructured":"Lutfy K, Hossain SM, Khaliq I, Maidment NT (2001) Orphanin FQ\/nociceptin attenuates the development of morphine tolerance in rats. Br J Pharmacol 134:529\u2013534. https:\/\/doi.org\/10.1038\/sj.bjp.0704279","journal-title":"Br J Pharmacol"},{"key":"783_CR25","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s007020100012","volume":"108","author":"T Mamiya","year":"2001","unstructured":"Mamiya T, Noda Y, Ren X, Nagai T, Takeshima H, UkaiM, Nabeshima T (2001) Morphine tolerance and dependence in the nociceptin receptor knockout mice. J Neural Transm (Vienna) 108:1349\u20131361. https:\/\/doi.org\/10.1007\/s007020100012","journal-title":"J Neural Transm (Vienna)"},{"key":"783_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1124\/jpet.103.051599","volume":"306","author":"CD Mandyam","year":"2003","unstructured":"Mandyam CD, ThakkerDR, Standifer KM (2003) Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivity. J Pharmacol Exp Ther 306:965\u2013972. https:\/\/doi.org\/10.1124\/jpet.103.051599","journal-title":"J Pharmacol Exp Ther"},{"key":"783_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/s0149-7634(00)00015-4","volume":"24","author":"JS Mogil","year":"2000","unstructured":"Mogil JS, Chesler EJ, Wilson SG, Juraska JM, Sternberg WF (2000) Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype. Neurosci Biobehav Rev 24: 375\u2013389. https:\/\/doi.org\/10.1016\/s0149-7634(00)00015-4","journal-title":"Neurosci Biobehav Rev"},{"key":"783_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1046\/j.1471-4159.1999.0730179.x","volume":"73","author":"NP Murphy","year":"1999","unstructured":"Murphy NP, Maidment NT (1999) Orphanin FQ\/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J Neurochem 73:179\u2013186. https:\/\/doi.org\/10.1046\/j.1471-4159.1999.0730179.x","journal-title":"J Neurochem"},{"key":"783_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(96)00322-3","volume":"75","author":"NP Murphy","year":"1996","unstructured":"Murphy NP, Ly HT, Maidment NT (1996) Intracerebroventricular orphanin FQ\/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats. Neuroscience 75:1\u20134. https:\/\/doi.org\/10.1016\/0306-4522(96)00322-3","journal-title":"Neuroscience"},{"key":"783_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/s0006-8993(99)01425-0","volume":"832","author":"NP Murphy","year":"1999","unstructured":"Murphy NP, Lee Y, Maidment NT (1999) Orphanin FQ\/nociceptin blocks acquisition of morphine place preference. Brain Res 832:168\u2013170. https:\/\/doi.org\/10.1016\/s0006-8993(99)01425-0","journal-title":"Brain Res"},{"key":"783_CR31","doi-asserted-by":"publisher","first-page":"116926","DOI":"10.1016\/j.lfs.2019.116926","volume":"237","author":"SA Nasser","year":"2019","unstructured":"Nasser SA, Afify EA (2019) Sex differences in pain and opioid mediated antinociception: Modulatory role of gonadal hormones. Life Sci 237: 116926. https:\/\/doi.org\/10.1016\/j.lfs.2019.116926","journal-title":"Life Sci"},{"key":"783_CR32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/(SICI)1096-9861(19991004)412:4<563::AID-CNE2>3.0.CO;2-Z","volume":"412","author":"CR Neal","year":"1999","unstructured":"Neal CR, Mansour JrA, Reinscheid R, Nothacker HP, Civelli O, AkilH, Watson SJ (1999) Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J Comp Neurol 412:563\u2013605","journal-title":"J Comp Neurol"},{"key":"783_CR33","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1471-0528.1996.tb09545.x","volume":"103","author":"C Olofsson","year":"1996","unstructured":"Olofsson C, Ekblom A, Ekman-Ordeberg G, Hjelm A, Irestedt L (1996) Lack of analgesic effect of systemically administered morphine or pethidine on labour pain. Br J Obstet Gynaecol 103: 968\u2013972. https:\/\/doi.org\/10.1111\/j.1471-0528.1996.tb09545.x","journal-title":"Br J Obstet Gynaecol"},{"key":"783_CR34","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/s0006-291x(02)02258-1","volume":"297","author":"YX Pan","year":"2002","unstructured":"Pan YX, Bolan E, Pasternak GW (2002) Dimerization of morphine and orphanin FQ\/nociceptin receptors: generation of a novel opioid receptor subtype. Biochem Biophys Res Commun 297:659\u2013663. https:\/\/doi.org\/10.1016\/s0006-291x(02)02258-1","journal-title":"Biochem Biophys Res Commun"},{"key":"783_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00213-010-2012-7","volume":"213","author":"CA Podlesnik","year":"2011","unstructured":"Podlesnik CA, Ko MC, Winger G, Wichmann J, Prinssen EP, Woods JH (2011) The effects of nociceptin\/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys. Psychopharmacology 213:53\u201360. https:\/\/doi.org\/10.1007\/s00213-010-2012-7","journal-title":"Psychopharmacology"},{"key":"783_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejphar.2007.10.031","volume":"579","author":"D Reiss","year":"2008","unstructured":"Reiss D, Wichmann J, Tekeshima H, KiefferBL, Ouagazzal AM (2008) Effects of nociceptin\/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine. Eur J Pharmacol 579:141\u2013148. https:\/\/doi.org\/10.1016\/j.ejphar.2007.10.031","journal-title":"Eur J Pharmacol"},{"key":"783_CR37","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.pain.2010.11.033","volume":"152","author":"MC Ribeiro-Dasilva","year":"2011","unstructured":"Ribeiro-Dasilva MC, Shinal RM, Glover T, Williams RS, Staud R, Riley JL, Fillingim RB (2011) Evaluation of menstrual cycle effects on morphine and pentazocine analgesia. Pain 152: 614\u2013622. https:\/\/doi.org\/10.1016\/j.pain.2010.11.033","journal-title":"Pain"},{"key":"783_CR38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejphar.2010.07.036","volume":"645","author":"K Rutten","year":"2010","unstructured":"Rutten K, De Vry J, Bruckmann W, Tzschentke TM (2010) Effects of the NOP receptor agonist Ro65-6570 on the acquisition of opiate-and psychostimulant-induced conditioned place preference in rats. Eur J Pharmacol 645:119\u2013126. https:\/\/doi.org\/10.1016\/j.ejphar.2010.07.036","journal-title":"Eur J Pharmacol"},{"key":"783_CR39","doi-asserted-by":"publisher","unstructured":"Ruzza C, Holanda VA, Gavioli EC, TrapellaC, Calo G (2019) NOP agonist action of cebranopadol counteracts its liabilityto promote physical dependence. Peptides 112: 101\u2013105. https:\/\/doi.org\/10.1016\/j.peptides.2018.12.001","DOI":"10.1016\/j.peptides.2018.12.001"},{"key":"783_CR40","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1111\/bph.12744","volume":"171","author":"W Schroder","year":"2014","unstructured":"Schroder W, Lambert DG, Ko MC, Koch T (2014) Functional plasticity of the N\/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists. Br J Pharmacol 171:3777\u20133800. https:\/\/doi.org\/10.1111\/bph.12744","journal-title":"Br J Pharmacol"},{"key":"783_CR41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.peptides.2009.12.028","volume":"31","author":"GM Scoto","year":"2010","unstructured":"Scoto GM, AricoG, Iemolo A, Ronsisvalle G, Parenti C (2010) Selective inhibition of the NOP receptor in the ventrolateral periaqueductal gray attenuates the development and the expression of tolerance to morphine-induced antinociception in rats. Peptides 31:696\u2013700. https:\/\/doi.org\/10.1016\/j.peptides.2009.12.028","journal-title":"Peptides"},{"key":"783_CR42","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1124\/jpet.113.209825","volume":"348","author":"M Sobczak","year":"2014","unstructured":"Sobczak M, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Sa\u0142aga M, Storr M, Kordek R, Ma\u0142ecka-Panas E, KrajewskaWM, Fichna J (2014) Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse modelof inflammatory bowel diseases. J Pharmacol Exp Ther 348:401\u2013409. https:\/\/doi.org\/10.1124\/jpet.113.209825","journal-title":"J Pharmacol Exp Ther"},{"key":"783_CR43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s0304-3959(02)00457-8","volume":"103","author":"EC Stoffel","year":"2003","unstructured":"Stoffel EC, Ulibarri CM, Craft RM (2003) Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats. Pain 103: 285\u2013302. https:\/\/doi.org\/10.1016\/s0304-3959(02)00457-8","journal-title":"Pain"},{"key":"783_CR44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejphar.2014.10.029","volume":"745","author":"DD Sukhtankar","year":"2014","unstructured":"Sukhtankar DD, LagorioCH, Ko MC (2014) Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats. Eur J Pharmacol 745:182\u2013189. https:\/\/doi.org\/10.1016\/j.ejphar.2014.10.029","journal-title":"Eur J Pharmacol"},{"key":"783_CR45","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1124\/pr.114.009209","volume":"68","author":"L Toll","year":"2016","unstructured":"Toll L, Bruchas MR, Calo G, Cox BM, Zaveri NT (2016) Nociceptin\/orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems. Pharmacol Rev 68:419\u2013457. https:\/\/doi.org\/10.1124\/pr.114.009209","journal-title":"Pharmacol Rev"},{"key":"783_CR46","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/adb.12550","volume":"23","author":"TM Tzschentke","year":"2018","unstructured":"Tzschentke TM, K\u00f6gel BY, Frosch S, Linz K (2018) Limited potential of cebranopadol to produce opioid-type physical dependence in rodents. Addict Biol 23:1010\u20131019. https:\/\/doi.org\/10.1111\/adb.12550","journal-title":"Addict Biol"},{"key":"783_CR47","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/s0304-3940(97)00832-x","volume":"237","author":"H Ueda","year":"1997","unstructured":"Ueda H, Yamaguchi T, Tokuyama S, Inoue M, Nishi M, Takeshima H (1997) Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene. Neurosci Lett 237:136\u2013138. https:\/\/doi.org\/10.1016\/s0304-3940(97)00832-x","journal-title":"Neurosci Lett"},{"key":"783_CR48","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1124\/jpet.108.136937","volume":"326","author":"GB Varty","year":"2008","unstructured":"Varty GB, Lu SX, Morgan CA, Cohen-Williams ME, Hodgson RA, Smith-Torhan A, Zhang H, Fawzi AB, Graziano MP, Ho GD, Matasi J, Tulshian D, Coffin VL, Carey GJ (2008) The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH221510). J Pharmacol Exp Ther 326:672\u2013682. https:\/\/doi.org\/10.1124\/jpet.108.136937","journal-title":"J Pharmacol Exp Ther"},{"key":"783_CR49","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1471-4159.2004.02921.x","volume":"92","author":"HL Wang","year":"2005","unstructured":"Wang HL, Hsu CY, Huang PC, Kuo YL, Li AH, Yeh TH, Tso AS, Chen YL (2005) Heterodimerization of opioid receptor-like 1 and mu-opioid receptors impairs the potency of micro receptor agonist. J Neurochem 92:1285\u20131294. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02921.x","journal-title":"J Neurochem"},{"key":"783_CR50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12031-018-1140-0","volume":"66","author":"Q Wu","year":"2018","unstructured":"Wu Q, Liu L (2018) ORL(1) Activation mediates a novel ORL(1) receptor agonist SCH221510 analgesia in neuropathic pain in rats. J Mol Neurosci 66:10\u201316. https:\/\/doi.org\/10.1007\/s12031-018-1140-0","journal-title":"J Mol Neurosci"},{"key":"783_CR51","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2174\/156802611795371341","volume":"11","author":"NT Zaveri","year":"2011","unstructured":"Zaveri NT (2011) The nociceptin\/orphanin FQ receptor (NOP) as a target for drug abuse medications. Curr Top Med Chem 11:1151\u20131156. https:\/\/doi.org\/10.2174\/156802611795371341","journal-title":"Curr Top Med Chem"},{"key":"783_CR52","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.neuropharm.2012.04.028","volume":"63","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Donica CL, Standifer KM (2012) Sex differences in the Nociceptin\/Orphanin FQ system in rat spinal cord following chronic morphine treatment. Neuropharmacology 63:427\u2013433. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.04.028","journal-title":"Neuropharmacology"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-021-00783-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-021-00783-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-021-00783-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T06:09:35Z","timestamp":1636524575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-021-00783-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["783"],"URL":"https:\/\/doi.org\/10.1007\/s11011-021-00783-8","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"assertion":[{"value":"20 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors state that there is no conflict of interest.\u00a0","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts\u00a0of interest"}},{"value":"All animal procedures were approved by the Institutional Review Committee for the Use of Animals (Beijing Institute of Pharmacology and Toxicology, China; Ethical approval number: IACUC of AMMS-06-2019-002) and were performed in accordance with the National Institutes of Health\u2019s Guide for the Care and Use of Laboratory Animals (NIH Publication No. 80\u2009\u2212\u200923). None of the authors performed any human experiments as part of this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have given their consent to participate the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have read the manuscript and given their consent for publication.\u00a0","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}